Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells

PURPOSE: Glioblastoma multiforme (GBM) remains highly incurable, with frequent recurrences after standard therapies of maximal surgical resection, radiation, and chemotherapy. To address the need for new treatments, we have undertaken a chimeric antigen receptor (CAR) “designer T cell” (dTc) immunot...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Kong, Seogkyoung, Sengupta, Sadhak, Tyler, Betty, Bais, Anthony J., Ma, Qiangzhong, Doucette, Saryn, Zhou, Jinyuan, Sahin, Ayguen, Carter, Bob S., Brem, Henry, Junghans, Richard P., Sampath, Prakash
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4337849/
https://ncbi.nlm.nih.gov/pubmed/22966020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0319
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires